GT Biopharma, Inc. (GTBP)
0.299
-0.01
(-2.22%)
USD |
NASDAQ |
Aug 25, 16:00
0.299
0.00 (0.00%)
After-Hours: 18:41
GT Biopharma Total Assets (Quarterly) : 5.788M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.788M |
| March 31, 2026 | 9.996M |
| December 31, 2025 | 8.106M |
| September 30, 2025 | 4.321M |
| June 30, 2025 | 7.124M |
| March 31, 2025 | 2.658M |
| December 31, 2024 | 4.232M |
| September 30, 2024 | 6.759M |
| June 30, 2024 | 9.267M |
| March 31, 2024 | 9.912M |
| December 31, 2023 | 14.11M |
| September 30, 2023 | 16.15M |
| June 30, 2023 | 18.14M |
| March 31, 2023 | 20.09M |
| December 31, 2022 | 16.74M |
| September 30, 2022 | 21.07M |
| June 30, 2022 | 24.17M |
| March 31, 2022 | 27.44M |
| December 31, 2021 | 32.17M |
| September 30, 2021 | 35.80M |
| June 30, 2021 | 39.57M |
| March 31, 2021 | 27.64M |
| December 31, 2020 | 5.661M |
| September 30, 2020 | 0.917M |
| June 30, 2020 | 1.063M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.295M |
| December 31, 2019 | 0.396M |
| September 30, 2019 | 0.482M |
| June 30, 2019 | 25.71M |
| March 31, 2019 | 25.54M |
| December 31, 2018 | 25.40M |
| September 30, 2018 | 26.54M |
| June 30, 2018 | 255.01M |
| March 31, 2018 | 257.33M |
| December 31, 2017 | 254.37M |
| September 30, 2017 | 256.52M |
| June 30, 2017 | 0.042M |
| March 31, 2017 | 0.238M |
| December 31, 2016 | 0.025M |
| September 30, 2016 | 0.16M |
| June 30, 2016 | 0.362M |
| March 31, 2016 | 0.037M |
| December 31, 2015 | 0.054M |
| September 30, 2015 | 0.049M |
| June 30, 2015 | 0.132M |
| March 31, 2015 | 1.425M |
| December 31, 2014 | 0.888M |
| September 30, 2014 | 0.71M |
| June 30, 2014 | 0.052M |
| March 31, 2014 | 0.103M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.219M |
| Shareholders Equity (Quarterly) | 3.569M |
| Current Ratio | 2.380 |